Incidence and inhospital outcomes of coronavirus disease 2019-associated pulmonary aspergillosis in the United States.

While CAPA is an infrequent complication during hospitalizations for COVID-19, it significantly increases all-cause mortality, prolongs hospital stays, and leads to higher hospital expenses compared to COVID-19 cases without aspergillosis.